Meet us at these fairs and symposiums

Innovation in surface disinfection in the pharmaceutical industry, not compromising with safety, performance and ease-of-use.

Airborne surface disinfection (ASD) has become an essential approach to ensuring safe and contamination-free production environments in the pharmaceutical industry.

At the A3P show in Tours, experts highlighted the importance of combining DSVA with barrier technologies such as RABS (Restricted Access Barrier Systems) and isolators. This synergy makes it possible to push back the limits of disinfection and maintain sterile, safe environments for the manufacture of vital medicines.

Reducing risks with ASD.

Automatic ASD works by diffusing disinfecting agents in mist form, covering all surfaces evenly. This method offers a number of advantages over traditional manual surface disinfection techniques. Firstly, it enables you to reach hard-to-reach areas and treat large surfaces in a short space of time.

What’s more, automatic DSVA eliminates the need to physically handle surfaces, reducing the risk of cross-contamination. Using appropriate disinfectants, DSVA can effectively eliminate bacteria, viruses, fungi and spores, creating a highly secure production environment.

Barrier technologies: a necessity to ensure safety for all.

However, to optimize the effectiveness of ASD, it is essential to combine this approach with the appropriate barrier technologies. RABS are restricted access barrier systems that prevent contamination of the production environment by limiting operator access and creating a physical separation between the operator and the production area. The integration of RABS with ASD ensures that disinfecting agents are confined within the production area, minimizing the risk of dispersal and external contamination. RABS also offer enhanced protection for operators, reducing their exposure to potentially dangerous pathogens.

Similarly, isolators play a crucial role in protecting sensitive operations and preventing cross-contamination. Isolators are hermetically sealed systems that enable hazardous substances to be handled in a controlled, confined environment. When combined with DSVA, isolators provide a double barrier of protection. The disinfecting agents released by the DSVA specifically target the surfaces inside the isolator, eliminating potentially present micro-organisms. This approach guarantees precise, targeted disinfection of critical areas, such as pharmaceutical product handling areas or package opening zones.

ASD: an important role in workplace safety.

Several concrete examples illustrate the effectiveness of integrating DSVA with barrier technologies. In the production of anti-cancer drugs, where the handling of potentially hazardous products is necessary, the combined use of DSVA, isolators and RABS helps to maintain optimal conditions of biocharge control while ensuring the safety of operators.

Similarly, in the manufacture of sensitive biological agents, DSVA combined with isolators eliminates the risk of contamination during delicate operations.

Barrier technologies and ASD: an effective combination.

In conclusion, the use of ASD in combination with barrier technologies such as RABS and isolators is revolutionizing surface disinfection in the pharmaceutical industry. This approach makes it possible to maintain highly sterile production environments, improve operator safety and prevent cross-contamination. A3P Tours has played a key role in highlighting these scientific advances and promoting their adoption in the industry.

Thanks to this synergistic combination, the pharmaceutical industry can continue to provide safe, high-quality medicines to meet society’s healthcare needs.

☛ Please do not hesitate to contact us to find out more about our services :